The global Synthetic Biology Market is expected to witness a stupendous CAGR in the years to come. This could be attributed to its presence across loads of end-users like industrial chemicals, agriculture, and healthcare. The synthetic biology market would be catalyzed further by extensive research along with collaboration of technology, science, and engineering for designing, redesigning, producing or modifying biological systems, genetic materials, and living organisms. The U.S., according to National Science Foundation, did invest close to $820 million between 2008 and 2014 in synthetic biology and is expected to continue with the same in the upcoming period as well.
Market Overview:
Food security has been a matter
of utmost concern off late. Population explosion, environmental stress, and
changing climate are adding to the concern. Factors like production of food
with much better shelf life, and tailored medicinal or nutritional value are
expected to bolster the applications of synthetic biology in agricultural and
food sector. At the same time, ethical risk and biosafety regarding synthetic
biology could hamper the expansion of business. The tools used in synthetic
biology as of now include Oligonucleotides, enzymes, cloning technology kits,
Chassis Organisms, and Xeno-Nucleic Acid.
Request free sample to get a complete analysis of top-performing
companies @ https://www.millioninsights.com/industry-reports/synthetic-biology-market/request-sample
Key Players:
ATUM,
Pareto Biotechnologies
OriGene Technologies, Inc.,
Integrated DNA Technologies,
Inc.,
GenScript,
Synthetic Genomics
Growth Drivers:
The synthetic biology market is
segmented based on product, application, technology, and geography. By product,
the market says core products, enabled products, and enabling products. By
technology, it spans DNA synthesis, DNA sequencing, computational modelling,
bioinformatics technology, nanotechnology, microfluidics technology, pathway
engineering, modular protein assembly, genome engineering, and synthetic
microbial consortia.
By application, the synthetic
biology industry says environmental (bioremediation, whole-cell biosensors),
and medical application (drug delivery therapeutics, pharmaceuticals,
artificial tissue and regeneration), and industrial application (biofuel and
renewable energy, industrial enzyme, food & beverages, paper industry, personal
care, biomaterials & green chemicals). By geography, the market says North
America (U.S., Canada, Mexico, and the Rest of North America), LATAM (Brazil,
Venezuela, Argentina, Costa Rica, Columbia, Peru, and the rest of LATAM),
Europe (U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark,
and the Rest of Europe), Asia Pacific (India and the rest of Asia Pacific), and
MEA.
Synthetic biology Technology Outlook (Revenue, USD Million, 2012 -
2020)
• DNA sequencing
• Genome engineering
• Biological Components and Integrated
Systems and Bioinformatics
The players contributing to the
synthetic biology market include ATUM, Pareto Biotechnologies, Inc., OriGene
Technologies, Inc., Integrated DNA Technologies, Inc., GenScript, Synthetic
Genomics, Inc. and Blue Heron Biotech, LLC. Organic growth is on the anvil. For
instance – Thermo Fisher Scientific, Inc., in 2018, did license its CRISPR
(Clustered Regularly Interspaced Short Palindromic Repeats) from Board
Institute and ERS Genomics University of California for enhancing its genome
editing IP portfolio.
Browse Related Category Research Reports @ https://millioninsightsmarket.wordpress.com
No comments:
Post a Comment